The activation of the Hh signaling pathway regulates drug sensitivity by directly upregulating ABCG2 expression in diffuse large B-cell lymphoma (DLBCL)39, ovarian cancer40,41, and gastric cancer42. Here, ABCG2 is linked to diffuse large B-cell lymphoma.